Seestrasse 16
Küsnacht CH-8700
Switzerland
+41 44 2676700
https://www.bbbiotech.ch/en/bb-biotech/
Settore/i:
Settore:
Impiegati a tempo pieno: 10
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
L'ISS Governance QualityScore di BB Biotech AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.